Project Grant HT94252410898
Award Date
8/1/24
Completion Date
7/31/26
Dollars Obligated
$299K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
St. Louis, MO 63110, USA
Similar Awards
The University of Houston was awarded a $750,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research into interleukin-15 (IL-15) in lupus from September 30, 2021 through September 29, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care through innovative...
The U.S. Department of Defense's Defense Health Agency awarded a $749,999 Project Grant to the University of Louisville's Office of Research & Innovation to support the "RESTORATION OF MACROPHAGE FUNCTION AS A STRATEGY TO PREVENT/TREAT LUPUS" research project. The grant, which runs from September 1, 2023 to August 31, 2026, is funded through the Military Medical Research and Development program (CFDA 12.420). This program supports a range of biomedical research aimed at...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program provides $999,465.00 to the University of Houston System to conduct research on selective spleen-targeted nanoparticles as drug delivery vehicles for the treatment of lupus. The research aims to advance disease prevention, diagnosis, treatment, and management of this condition through basic, applied, and translational research initiatives. The award...
This Project Grant award of $997,821.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research on the pathogenic role of neutrophil subpopulations in lupus nephritis. The primary awardee is Trustees of Dartmouth College, who will conduct this research over a three-year period from November 1, 2024 to October 31, 2027. The project involves two sub-awards: one to The Johns Hopkins University to contribute expertise, and...
The Department of the Army Medical Command awarded a $750,000 Project Grant to The Trustees of Columbia University in the City of New York under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant aims to validate Systemic Lupus Erythematosus (SLE) virtual outcome measures through three specific objectives over a three-year period ending August 2024. Sub-awards were provided to six institutions, including the Oklahoma Medical Research Foundation and the...
The Department of the Army Medical Command awarded Monash University a $1,498,168 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support research on Targeted Regulatory T Cells to Treat SLE from September 1, 2022 through August 31, 2025. Under this award, Monash University will conduct research to investigate medical solutions for systemic lupus erythematosus (SLE) by developing targeted regulatory T cells as an innovative treatment approach. The...
The federal Project Grant award, ID HT94252410597, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $300,000.00 award, effective September 1, 2024 through August 31, 2026, will support research conducted by Duke University to study the "complement-activating properties of anti-SM/RNP antibodies in SLE". The research aims to advance scientific understanding and potential medical solutions related to this area of...
The Johns Hopkins University was awarded a $750,000 Project Grant from the Department of the Army Medical Command to study the role of complement in the antiphospholipid antibody syndrome in patients with systemic lupus erythematosus (SLE). The three-year award, issued on September 15, 2021 with a completion date of September 14, 2024, will fund research into medical solutions for the battlefield under the Military Medical Research and Development program (CFDA 12.420). This program supports...
The federal Project Grant award, valued at $250,000.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Washington University's Office of Sponsored Research Services Division. The award will fund a study on the "SUBCLINICAL PATHOPHYSIOLOGY OF MOTOR PROCESSING IN PEOPLE WITH MULTIPLE SCLEROSIS" over a 2-year period from September 30, 2024 to September 29, 2026. As a prominent private research university, The...
The Department of the Army Medical Command awarded a $1,499,782 Project Grant to the New York Society For Relief Of Ruptured & Crippled Maintaining The Hospital For Special Surgery under the Military Medical Research and Development program. This three-year award beginning July 1, 2022 will support research into photosensitivity and lymph node immune responses in lupus. The Military Medical Research and Development program aims to advance biomedical research that improves health care for...